Weight-loss drugs have experienced a remarkable rise in the UK since their approval in 2023. As many as 1.5 million Britons are now reported to be using GLP-1 medications for
Weight-loss drugs have experienced a remarkable rise in the UK since their approval in 2023. As many as 1.5 million Britons are now reported to be using GLP-1 medications for
Britain’s largest private hospital operator, Spire Healthcare Group, is reportedly in discussions with major private equity firms, including Bridgepoint and Triton Partners, regarding a potential acquisition that could value the
GlaxoSmithKline (GSK) has announced its acquisition of a US biopharmaceutical company, RAPT Therapeutics, for a sum of 2.2 billion dollars. This strategic move marks GSK’s first bolt-on acquisition under the
British expatriates residing in France may soon face significant changes to their access to free healthcare as French lawmakers advance measures to close a longstanding loophole. Presently, expats not engaged
Weight loss medications, specifically GLP1 agonists like Ozempic Wegovy and Mounjaro, are redefining the landscape of healthcare in Britain, with new research signposting not only longer lives for millions but
Assura the NHS landlord at the centre of a lengthy bidding war has reported strong annual results that strengthen shareholder resolve to resist a buyout by private equity. The FTSE
WeightWatchers is embarking on a transformative journey following a significant debt restructuring, positioning itself to compete in the evolving landscape of weight management solutions. The company, which recently emerged from
Private healthcare giant Bupa has been ordered to pay £17 million in compensation to Australian members following revelations that the company deliberately blocked legitimate health insurance claims. The Australian Competition
The UK’s leading pharmacy and retail chain Boots has delivered another robust quarter of growth, marking its 17th consecutive period of market share gains amid an impending £10 billion private
The National Health Service faces a mounting crisis as overseas-trained medical professionals increasingly opt for more lucrative positions in the United States, Australia, and Canada, according to new research from
The NHS is embarking on a significant initiative aimed at removing up to 300,000 patients from its waiting lists in an effort to streamline operations and enhance patient care. This
Almost £8 billion has been erased from the value of the world’s largest pharmaceutical companies following the unexpected ousting of America’s leading vaccine authority by Robert F Kennedy Jr. Shares
In an unprecedented shift within the underground pharmaceutical market, drug dealers across the UK are diversifying their offerings to include sought-after weight-loss medications alongside traditional illicit substances. The weight-loss injection
Spire Healthcare, the UK’s largest private healthcare provider, is witnessing unprecedented growth amid mounting NHS pressures. The FTSE 250-listed organisation has strategically positioned itself as a crucial partner in addressing
In a significant move strengthening its technological capabilities, AstraZeneca has appointed Arm Holdings Chief Executive Rene Haas to its board as a non-executive director, effective from next month. The appointment
British pharmaceutical giant GSK has held firm on its annual group forecasts despite experiencing a decline in vaccine sales, with strong performance in specialist medicines helping to offset the downturn.






